Clinical Trial: A Study to Evaluate the Efficacy and Safety of IN-207907 Injection in Elderly Patients With Sarcopenia

U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07668180) titled 'A Study to Evaluate the Efficacy and Safety of IN-207907 Injection in Elderly Patients With Sarcopenia' on June 16.

Brief Summary: The goal of this clinical trial is to learn if intervention can treat sarcopenia in the elderly. Researchers will compare IN-207907 120 mg, 240 mg, 360 mg and placebo to see if SPPB score improves.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Sarcopenia in Elderly

Intervention: DRUG: IN-207907 120 mg

IN-207907 120 mg will be administered by intravenous injection at 4-week intervals for a total of 3 doses.

DRUG: IN-207907 240 mg

IN-207907 240 mg will be administered by intr...